Keywords: roche, decides, expand, ph, ii, cias, trial

Roche decides to expand Ph II CIAS trial

Article | 29 September 2008

Print This

The USA's Memory Pharmaceuticals has amended its nicotinic alpha-7 receptor agonist agreement with Roche to expand the Phase II development ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in